Johnson & Johnson’s year of lawsuits

Sign-up to one of our many Group Actions today - use our quick and easy form to start your claim for compensation.

Begin Your Group Action Claim Today

Select Enquiry Type To Begin

Select Emissions Manufacturer

Please note we are unable to proceed with claims involving BMW, Dacia, Ford, Honda, MINI, Mercedes-Benz & Mitsubishi.

Select Nissan/Renault Model

Select Porsche Model

Select Jaguar Land Rover Model

Select Fiat Chrysler Model

Enter Vehicle Manufacturer

Enter Vehicle Model

Is your vehicle fitted with an EA189 engine, or a newer engine?

The deadline for claims for EA189 engines passed in 2018, and claims settled in 2022. We are unable to take any claims on for vehicles with EA189 engines. We are able to take on claims for newer engine types that are NOT EA189 engines.

Breach Type

Select Group Action

Enter Other Group Action

Title

Enter Other Title Here

First Name

Surname

Contact Number

E-Mail

Call Back Details

Our claims team will call you back at a time that's suitable to you.

Select Other Call Back Date & Time

Please fix the above errors and resubmit.

Your privacy is extremely important to us.
Information on how we handle your data is in our Privacy Policy

Johnson & Johnson’s year of lawsuits

The worldwide company Johnson & Johnson has been on the end of some monumental compensation claims and group actions across the globe.

The year of 2016 was quite the whirlwind year for Johnson & Johnson; they reportedly lost 6 out of 7 jury verdicts in the U.S. as a result of ‘defective’ products. According to Bloomberg, this year isn’t looking any better.

2016 lawsuits

As a general rule of thumb, companies wouldn’t normally face more than 2 or 3 product defect verdicts above $20 million (£15 million) in one year – Johnson & Johnson lost 6 verdicts – and each were valued at more than $50 million (£37 million).

The pharmaceutical and medical devices manufacturer was hit with:

2 hip implant verdicts amounting to $1 billion (£772 million) and $500 million (£386 million). The $1 billion verdict is reported to be the 7^th largest product-defect pay out in U.S. history. The Dallas jury found that the metal-on-metal Pinnacle hip implants were defectively designed, causing excruciating pain and requiring replacement surgeries. The lawsuits alleged that the company failed to warn users of that risk. Both Johnson & Johnson and DePuy have been struck with around 9,400 lawsuits in relation to the devices, with the numbers still on the rise.
3 talcum-powder verdicts amounting to $72 million (£56 million), $70 million (£54 million) and $55 million (£42 million) tried in a St. Louis court. Women alleged that they had developed ovarian cancer from the use of the talcum-based products, including the well-known baby powder. Although Johnson & Johnson deny there is a link between the use of the talcum-based products and ovarian cancer, they still paid out such a large amount of money to their victims. But why would an innocent company pay out? There is a body of scientific research that supports the claim that talcum powder and ovarian cancer are linked…
A Risperdal drug verdict amounting to $70 million (£54 million) tried in the Philadelphia court – a Tennessee teenager, Andrew Yount, blamed the use of the drug for causing him to grow breasts. The Philadelphia jury found that the company failed to warn the risks of growing breast tissue. He was awarded damages for emotional distress. This verdict is 30 times larger than the award given to an Alabama man, Austin Pledger, who sued the company for developing size 46DD breasts as a result of taking the drug. In 2015, Austin was awarded $2.5 million (£1.9 million).

Denied liability

For the vast majority of the lawsuits, Johnson & Johnson denied liability for the injuries inflicted on the victims. As mentioned above, Johnson & Johnson say there’s no scientific evidence linking the use of their talcum-based products and ovarian cancer, and in the Risperdal claims, Johnson & Johnson state that both patients and doctors were sufficiently warned about the side effects.

No signs of slowing down

There are multiple group actions going on in relation to the above products. No wonder Johnson & Johnson are facing more than 100,000 claims over these products, and there aren’t any signs of it slowing down. This is shown recently as Johnson & Johnson were ordered to pay $110 million (£85 million) to Lois Slemp who says that the use of the baby powder caused her to develop ovarian cancer.

Johnson & Johnson is facing at least 17 trials in U.S. courts over hip implants, talcum powder, pelvic mesh, an anti-psychotic drug and a blood thinner this year alone. The publicity of the lawsuits only encourages more people to come forward, thus Johnson & Johnson should watch their backs as the numbers are only going to increase.

Sources:

http://www.dailymail.co.uk/news/article-2972564/Risperdal-producers-award-autistic-man-2-5million-damages-grew-size-46DD-breasts-effect-drug-took-boy.html
https://www.bloomberg.com/news/articles/2016-07-01/j-j-faces-record-70-million-verdict-over-male-breasts
http://uk.reuters.com/article/us-johnson-johnson-verdict-hipimplants-idUKKBN13Q5XF
http://www.bbc.co.uk/news/world-us-canada-39816799
https://www.bloomberg.com/news/articles/2017-03-28/why-johnson-johnson-would-like-to-forget-2016-quicktake-q-a?cmpid=yhoo.headline

Start Your Claim Now!

The content of this post/page was considered accurate at the time of the original posting and/or at the time of any posted revision. The content of this page may, therefore, be out of date. The information contained within this page does not constitute legal advice. Any reliance you place on the information contained within this page is done so at your own risk.

$3.4 billion (£2.6 billion) settlement agreement for Toyota’s rusty truck frames

Medical device maker Medtronic has recalled their adjustable pressure valves across the world

Johnson & Johnson’s year of lawsuits

Johnson & Johnson’s year of lawsuits

2016 lawsuits

Denied liability

No signs of slowing down

Share this:

Related